Literature DB >> 9195569

Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors.

B Delahunt1, J N Eble.   

Abstract

Papillary renal cell carcinoma is the second most common carcinoma of the renal tubules and has been characterized genetically. Its morphologic features are incompletely characterized. It has been suggested that the presence of cytokeratin 7 is specific for papillary renal cell carcinoma. Collecting duct carcinoma might have papillary architecture, and it has been suggested that reaction with the Ulex europaeus lectin is specific for it. Sections from 105 papillary renal cell carcinomas larger than 12 mm in diameter from 100 patients were studied, and immunohistochemical reactions were performed on 91. The tumors formed two morphologic groups. Type 1 (67 tumors) consisted of papillae and tubular structures covered by small cells with pale cytoplasm and characterized by small oval nuclei with inconspicuous nucleoli, frequent glomeruloid papillae, papillary edema, foamy macrophages in papillary cores, and psammoma bodies. Type 2 (38 tumors) consisted of papillae covered by large cells with abundant eosinophilic cytoplasm and characterized by pseudostratification and large spherical nuclei with prominent nucleoli, glomeruloid papillae, psammoma bodies, edematous papillae, and foamy macrophages in papillary cores are uncommon. Type 2 tumors were larger, more common in patients younger than age 40, and more frequently Stages 3 or 4 than were Type 1 tumors. Pseudocapsules were common in both and often were infiltrated by carcinoma. Sarcomatoid foci were found in five tumors. Eleven were stage T1, 54 T2, 23 T3, and 12 T4. Reaction for cytokeratin 7 was strong or moderate in 48 of 61 Type 1 tumors, and reaction was null in 24 of 30 Type 2 tumors. No tumor reacted with U. europaeus lectin.

Entities:  

Mesh:

Year:  1997        PMID: 9195569

Source DB:  PubMed          Journal:  Mod Pathol        ISSN: 0893-3952            Impact factor:   7.842


  154 in total

1.  Typical signs of oncocytic papillary renal cell carcinoma in everyday clinical praxis.

Authors:  T Urge; O Hes; J Ferda; Z Chudácek; V Eret; M Michal; M Brunelli; G Martignoni; M Hora
Journal:  World J Urol       Date:  2010-05-08       Impact factor: 4.226

2.  Papillary renal cell carcinoma in allograft kidney.

Authors:  Catherine Roy; Sofiane El Ghali; Xavier Buy; Véronique Lindner; Afshin Gangi
Journal:  Eur Radiol       Date:  2004-09-17       Impact factor: 5.315

3.  Pediatric Renal Cell Carcinoma.

Authors:  Elizabeth J Perlman
Journal:  Surg Pathol Clin       Date:  2010-09-01

4.  MRI evaluation of small (<4cm) solid renal masses: multivariate modeling improves diagnostic accuracy for angiomyolipoma without visible fat compared to univariate analysis.

Authors:  Nicola Schieda; Marc Dilauro; Bardia Moosavi; Taryn Hodgdon; Gregory O Cron; Matthew D F McInnes; Trevor A Flood
Journal:  Eur Radiol       Date:  2015-10-20       Impact factor: 5.315

5.  MR Imaging of papillary renal neoplasms: potential application for characterization of small renal masses.

Authors:  Catherine Roy; Benoit Sauer; Véronique Lindner; Hervé Lang; Christian Saussine; Didier Jacqmin
Journal:  Eur Radiol       Date:  2006-06-07       Impact factor: 5.315

6.  [Renal cell carcinoma].

Authors:  A Haferkamp; D Rohde; S C Müller; H Rübben; M Hohenfellner
Journal:  Urologe A       Date:  2006-09       Impact factor: 0.639

7.  Deregulation of E2-EPF ubiquitin carrier protein in papillary renal cell carcinoma.

Authors:  Frederik C Roos; Andrew J Evans; Walburgis Brenner; Bill Wondergem; Jeffery Klomp; Pardeep Heir; Olga Roche; Christian Thomas; Heiko Schimmel; Kyle A Furge; Bin T Teh; Joachim W Thüroff; Christian Hampel; Michael Ohh
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

8.  Tumor-associated macrophages are involved in tumor progression in papillary renal cell carcinoma.

Authors:  Carl Ludwig Behnes; Felix Bremmer; Bernhard Hemmerlein; Arne Strauss; Philipp Ströbel; Heinz-Joachim Radzun
Journal:  Virchows Arch       Date:  2013-12-11       Impact factor: 4.064

9.  Concomitant Heart, Ovaries, and Renal Neoplasms: Atypical Findings During Hypertension Evaluation.

Authors:  Igor Duquesne; Rafael Sanchez-Salas; Konstantinos Zannis; Richard Berry; Lee Nguyen; Eric Barret; Aude Fregeville; Pierre Validire; Xavier Cathelineau
Journal:  Curr Urol Rep       Date:  2016-12       Impact factor: 3.092

10.  Metastatic type-2 papillary renal cell carcinoma responded to interleukin-2 therapy: case report.

Authors:  Takeo Kosaka; Shuji Mikami; Akira Miyajima; Mototsugu Oya
Journal:  Clin Exp Nephrol       Date:  2008-01-22       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.